Company Filing History:
1 out of 832,891 Years Active: 2002
Title: Cary Geary: Innovator in Ciliary Dyskinesia Treatment
Introduction
Cary Geary is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medical treatment, particularly in addressing ciliary dyskinesia. His innovative approach has the potential to improve the quality of life for patients suffering from this condition.
Latest Patents
Cary Geary holds a patent for a method of treating ciliary dyskinesia with uridine triphosphates and related compounds. This method involves stimulating ciliary beat frequency in a subject in need of such treatment. The process includes administering a triphosphate nucleotide, such as uridine 5′-triphosphate (UTP), to various parts of the body, including the airways, ears, eyes, or genito-urinary tract. This treatment is particularly beneficial for patients afflicted with ciliary dyskinesia, Kartagener's syndrome, or other diseases involving dysfunction of ciliary movement. The patent also covers pharmaceutical formulations and methods of administration, which can include liquid suspensions, oral intake, inhalation, topical application, and more.
Career Highlights
Cary Geary has achieved recognition for his innovative work in the medical field. His patent represents a significant advancement in the treatment of conditions related to ciliary dysfunction. With a focus on improving patient outcomes, Geary's contributions are paving the way for new therapeutic options.
Collaborations
Cary Geary has collaborated with notable colleagues, including Karla M Jacobus and Benjamin R Yerxa. These partnerships have likely enhanced the development and application of his innovative methods.
Conclusion
Cary Geary's work in developing a method for treating ciliary dyskinesia showcases his commitment to advancing medical science. His patent reflects a significant step forward in addressing complex health issues related to ciliary movement. Through his innovations, Geary is making a meaningful impact on patient care and treatment options.